Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19.
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19.
复制标题
DOI:
10.1371/journal.pone.0243025
复制
发表时间:
2020
期刊:
影响因子:
3.7
通讯作者:
Hatzakis A
中科院分区:
文献类型:
--
作者:
Psichogiou M;Karabinis A;Pavlopoulou ID;Basoulis D;Petsios K;Roussos S;Pratikaki M;Jahaj E;Protopapas K;Leontis K;Rapti V;Kotanidou A;Antoniadou A;Poulakou G;Paraskevis D;Sypsa V;Hatzakis A
Greece is a country with limited spread of SARS-CoV-2 and cumulative infection attack rate of 0.12% (95% CI 0.06–0.26). Health care workers (HCWs) are a well-recognized risk group for COVID-19. The study aimed to estimate the seroprevalence of antibodies to SARS-CoV-2 in a nosocomial setting and assess potential risk factors. HCWs from two hospitals participated in the study. Hospital-1 was a tertiary university affiliated center, involved in the care of COVID-19 patients while hospital-2 was a tertiary specialized cardiac surgery center not involved in the care of these patients. A validated, CE, rapid, IgM/IgG antibody point-of-care test was used. Comparative performance with a reference globally available assay was assessed. 1,495 individuals consented to participate (response rate 77%). The anti-SARS-CoV-2 weighted prevalence was 1.26% (95% CI 0.43, 3.26) overall and 0.53% (95% CI 0.06, 2.78) and 2.70% (95% CI 0.57, 9.19) in hospital-1 and hospital-2, respectively although the study was underpowered to detect statistically significant differences. The overall, hospital-1, and hospital-2 seroprevalence was 10, 4 and 22 times higher than the estimated infection attack rate in general population, respectively. Suboptimal use of personal protective equipment was noted in both hospitals. These data have implications for the preparedness of a second wave of COVID-19 epidemic, given the low burden of SARS-CoV-2 infection rate, in concordance with national projections.
登录
查看更多内容
DOI:
10.1016/s1473-3099(20)30634-4
发表时间:
2020-12
期刊:
The Lancet. Infectious diseases
影响因子:
--
作者:
National SARS-CoV-2 Serology Assay Evaluation Group
通讯作者:
National SARS-CoV-2 Serology Assay Evaluation Group
影响因子:
2.2
作者:
Kim, Jaeho;Kim, Moon-Moo
通讯作者:
Kim, Moon-Moo
影响因子:
13.8
作者:
Kluytmans-van Den Bergh, Marjolein F. Q.;Buiting, Anton G. M.;Kluytmans, Jan A. J. W.
通讯作者:
Kluytmans, Jan A. J. W.
影响因子:
8.8
作者:
Korth, Johannes;Wilde, Benjamin;Herrmann, Anke
通讯作者:
Herrmann, Anke
影响因子:
4.4
作者:
Brandstetter, Susanne;Roth, Samra;Kabesch, Michael
通讯作者:
Kabesch, Michael